By signing in or creating an account, you agree with Associated Broadcasting Company's Terms & Conditions and Privacy Policy.
Kolkata: Suddenly there is a rise in healthcare IPOs in India. Gujarat Kidney and Super Speciality IPO is a mainboard public issue which is designed to mobilise Rs 250.08 crore through only fresh shares. The issue managers have successfully raised Rs 100 crore from anchor investors, the list of which features names such as Venus Investments VCC – Venus Stellar Fund, Khandelwal Finance Private Limited, Craft Emerging Market Fund PCC Citadel Capital Fund, Nexus Global Opportunities Fund, Arnesta Global Opportunities Fund PCC – Arnesta Global Fund 1, Zeta Global Funds – Zeta Series C Fund PC, Innovative Vision Fund, Religo Commodities Ventures Trust and Sunrise Investment Trust. The company allocated 87,73,120 equity shares to anchor investors.
According to investorgain, Gujarat Kidney IPO GMP stood at Rs 7 on Dec 20. Considering a price band of Rs 114.00, the estimated listing price of Gujarat Kidney IPO is Rs 121. Therefore, at this level the listing gain will be 6.14%. Interestingly, the GMP stood at Rs 10 on Dec 18. On Dec 19, it declined to Rs 7 and on Dec 20, it stayed at that level. However, it must be kept in mind that GMP is an unofficial indicator that can vary quickly with time and cannot guarantee anything -- gain or loss on listing.
Gujarat Kidney IPO price band has been set at Rs 108-114. For a retail investor, the minimum investible lot is 128 and the minimum application amount that a retail investor has to commit is Rs 14,592 based on the upper price. The smallest lot size investment for sNII investors is 1,792 shares and that for bNII investors it is 8,832 shares. Nirbhay Capital Services has been appointed the lead manager and MUFG Intime the registrar to the issue.
IPO bid opens: Dec 22, 2025
IPO bid closes: Dec 24
Cut-off time for UPI mandate confirmation: 5 pm on Dec 24
Allotment: Dec 26
Refund: Dec 29
Credit of shares to demat: Dec 29
Listing: Dec 30
The company operates seven multispeciality hospitals and four pharmacies with a total capacity of 490 beds. The hospitals include Gujarat Kidney and Superspeciality Hospital (Vadodara), Gujarat Multispeciality Hospital (Godhra), Raj Palmland Hospital Private Limited (Bharuch), M/s. Surya Hospital and ICU (Borsad), Gujarat Surgical Hospital (Vadodara), and Ashwini Medical Centre (Anand). The company also operates Ashwini Medical Store (Anand).
(Disclaimer: This article is only meant to provide information. TV9 does not recommend buying or selling shares or subscriptions of any IPO, Mutual Funds, precious metals, commodity, any form of alternative investment instruments and crypto assets.)